Stocktoria
Forte Biosciences, Inc. FBRX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2017-04-13
Forte Biosciences, Inc. statistics & valuation
Market cap$430.7M
P / B7.1×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -83.8% | -57.6% | -80.7% | -33.0% | -50.1% |
| Return on equity | -113.7% | -67.6% | -89.1% | -35.8% | -52.2% |
| Current ratio | 3.88 | 6.76 | 10.45 | 13.06 | 24.19 |
Source: SEC EDGAR filings · CIK 0001419041 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.